Epic Sepsis Model vs MyoVista wavECG
openFDA returns one record for HeartSciences, K260005 for the MyoVista wavECG, decided October 5, 2026. The clearance does not include an AI-ECG algorithm, and the company's release says it does not intend to commercialize the device without one, with no timeline. The same release announces a business combination with Fortitude Mining Holdings, expected to close in the fourth quarter of 2026.
Epic hospitals get the Epic Sepsis Model inside their EHR. In its 2021 validation at Michigan Medicine, across 38,455 hospitalizations, it missed 67 percent of sepsis cases at an AUROC of 0.63 while alerting on 18 percent of hospitalizations.
HeartSciences sells to cardiology clinics, which share no purchase with a hospital's inpatient risk score. Today a clinic gets a 12-lead resting ECG with advisory interpretive statements for adults and children, plus the MyoVista Insights software, which lists an Epic showroom entry. No price is public.
Decision support · Reviewed November 2, 2026
Epic Sepsis Model
by Epic Systems
Sepsis risk score calculated every 15 minutes inside the Epic EHR, with alert thresholds set by each hospital.
MyoVista wavECG
by HeartSciences
12-lead resting ECG device for cardiology clinics, FDA 510(k) cleared in October 2026 without its AI-ECG algorithm.
When to pick each one
Epic Sepsis Model
- Risk score built into the Epic EHR
- Covers adult inpatients and ED patients
MyoVista wavECG
- 12-lead resting ECG, 510(k) cleared October 2026
- Epic showroom listing for MyoVista Insights
Score
Each row shows points earned of points available under the published rubric.
Epic Sepsis Model
41of 100
MyoVista wavECG
31of 100
| Dimension | Epic Sepsis Model | MyoVista wavECG | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 12 / 12 | -12 |
| HIPAA / SOC2 / BAA | 0 / 10 | 6 / 10 | -6 |
| EHR integrations (count) | 0 / 5.6 | 1.7 / 5.6 | -1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 1.9 / 4.8 | -1.9 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 21 / 21 | 0 / 21 | +21 |
| RCT / meta-analysis / systematic review | 9 / 9 | 0 / 9 | +9 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Epic Sepsis Model
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Delivered within Epic licensing. |
MyoVista wavECG
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Epic Sepsis Model
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
5 PubMed records name Epic Sepsis Model.
- A Systematic Review and Meta-analysis of Externally Validated Epic Clinical Decision Support Tools. (opens in new tab)
- Evaluation of Sepsis Prediction Models before Onset of Treatment. (opens in new tab)
- Multicenter Prospective Validation of an Updated Proprietary Sepsis Prediction Model. (opens in new tab)
MyoVista wavECG
FDA decisions
K260005 (opens in new tab)510(k)2026-10-05
MyoVista wavECG (DG-200-B15-003)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Epic Sepsis Model | MyoVista wavECG |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic |
| Founded | n/a | n/a |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.